Ftse Mib
36.179,84
0,19%
DAX
21.394,93
-0,11%
S&P 500
6.096,77
-0,36%
NASDAQ
19.907,88
-0,73%
Bitcoin
106.479,94
2,42%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunovant Inc (IMVT) Immunovant Inc (IMVT) Notizie

Immunovant Inc

IMVT
23,24
-0,16 (-0,68%)
Ultimo aggiornamento: 20:11:23
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202519:34PRNUSKuehn Law Encourages Investors of Immunovant, Inc. to..
21/1/202523:16EDGAR2Form D - Notice of Exempt Offering of Securities
17/1/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202514:09EDGAR2Form 8-K - Current report
13/1/202514:07EDGAR2Form 8-K - Current report
13/1/202514:00GLOBEImmunovant Announces $450 Million Private Placement
10/1/202522:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/11/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/11/202412:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:42EDGAR2Form 8-K - Current report
07/11/202412:30GLOBEImmunovant Provides Development Updates and Reports..
29/10/202411:30GLOBEImmunovant Announces Oral Presentation of Late Breaking..
25/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202413:40EDGAR2Form 8-K - Current report
09/9/202413:00GLOBERoivant Provides Update on Graves’ Disease Development..
09/9/202409:55GLOBEImmunovant Provides Update on Graves’ Disease Development..
05/9/202412:30GLOBEImmunovant to Host Graves’ Disease Program Update on..
23/8/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:12EDGAR2Form 8-K - Current report
06/8/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:13EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEImmunovant Reports Financial Results and Provides Corporate..
26/7/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:36EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/5/202422:17EDGAR2Form 8-K - Current report
29/5/202422:01GLOBEImmunovant Provides Corporate Updates and Reports Financial..
Apertura: 23,38 Min: 23,07 Max: 23,57
Chiusura: 23,40

La tua Cronologia

NASDAQ
IMVT
Immunovant
BIT
Q00245
Leonteq Securities
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network